Acadian Asset Management’s CONMED CNMD Stock Holding History

Acadian Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$678K	Sell	20,734 -49,976	-71%	-$1.8M	﹤0.01%	1367
2026 Q1	$2.5M	Buy	70,710 +58,066	+459%	+$2.36M	﹤0.01%	898
2025 Q4	$512K	Buy	12,644 +3,945	+45%	+$172K	﹤0.01%	1300
2025 Q3	$408K	Buy	+8,699	New	+$451K	﹤0.01%	1264
2024 Q4	–	Sell	-4,121	Closed	-$296K	–	1716
2024 Q3	$296K	Buy	+4,121	New	+$291K	﹤0.01%	1235
2020 Q4	–	Sell	-343	Closed	-$27K	–	2216
2020 Q3	$27K	Sell	343 -48,751	-99%	-$3.98M	﹤0.01%	2009
2020 Q2	$3.53M	Sell	49,094 -1,886	-4%	-$131K	0.02%	559
2020 Q1	$2.92M	Buy	50,980 +35,500	+229%	+$3.27M	0.02%	499
2019 Q4	$1.73M	Buy	+15,480	New	+$1.65M	0.01%	731
2019 Q3	–	Sell	-803	Closed	-$69K	–	1892
2019 Q2	$69K	Sell	803 -17,759	-96%	-$1.46M	﹤0.01%	1433
2019 Q1	$1.54M	Buy	18,562 +10,990	+145%	+$798K	0.01%	760
2018 Q4	$486K	Sell	7,572 -232	-3%	-$15.9K	﹤0.01%	911
2018 Q3	$618K	Buy	7,804 +4,543	+139%	+$351K	﹤0.01%	840
2018 Q2	$239K	Buy	+3,261	New	+$222K	﹤0.01%	1038
2014 Q3	–	Sell	-7,977	Closed	-$352K	–	1058
2014 Q2	$352K	Sell	7,977 -27,072	-77%	-$1.23M	﹤0.01%	735
2014 Q1	$1.52M	Buy	35,049 +31,817	+984%	+$1.42M	0.01%	523
2013 Q4	$137K	Buy	3,232 +748	+30%	+$28.4K	﹤0.01%	845
2013 Q3	$84K	Sell	2,484 -22,124	-90%	-$722K	﹤0.01%	822
2013 Q2	$769K	Buy	+24,608	New	+$798K	0.01%	519

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Acadian Asset Management's CNMD Position: Q2 2026 in Review

Acadian Asset Management reduced its CONMED (CNMD) stake by 71% in Q2 2026, selling an estimated $1.8M and leaving 20,734 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Acadian Asset Management first reported a position in CNMD in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.53M in Q2 2020. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Acadian Asset Management held 20,734 shares of CONMED worth $678K as of Q2 2026.
Acadian Asset Management sold 49,976 CONMED shares in Q2 2026, an estimated $1.8M.
CONMED made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1367 holding.
Acadian Asset Management first reported a position in CONMED in Q2 2013 and has held it in 19 quarters since.
Acadian Asset Management's CONMED position peaked at $3.53M in Q2 2020.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.